{content}

Study list

STD-MAR/Mpox

Spain
|
2023
  • Adults
  • People at high risk of STIs
  • People living with HIV
  • PrEP users
  • Hospital wide
  • Outpatient clinic
  • Monkeypox virus
  • Monkeypox virus infection
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • JYNNEOS

Bellmann-Strobl

Germany
|
2023-2025
  • Adults
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • vasodilator
  • Vericiguat

BLOC

Austria Finland Germany Spain Switzerland
|
2023-2024
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • BC 007

Dalton

United Kingdom
|
2023-2023
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Probiotic

PYCNOVID

Switzerland
|
2023-2024
  • General population
  • Elderly
  • Adult
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Pycnogenol

Jacobi

Germany
|
2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Plaza

Spain
|
2023-2025
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

STWandRVD

Italy
|
2023-2023
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Hydrotherapy

EJerSA-COVID-19

Spain
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Physical activity

PanoramicNOR

Norway
|
2023-2026
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

IAMPOCO

Germany
|
2023-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

Fellerhoff

Germany
|
2023
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Fimo Health App